NCT00861965: Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers |
|
|
| Terminated | 1/2 | 2 | US | AlloStim-8 | Immunovative Therapies, Ltd. | Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma | 03/11 | 04/11 | | |
NCT00558675: A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy |
|
|
| Completed | 1/2 | 6 | RoW | AlloStim | Immunovative Therapies, Ltd., Hadassah Medical Organization | Hematological Malignancy, Leukemia, Lymphoma, Multiple Myeloma | 12/12 | 03/13 | | |
